You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 3, March 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Ocular Melanoma-Associated Antigen

Molecular Characterization

Ming X. Wang, MD, PhD; James J. Earley, Jr, MS; Jerry A. Shields, MD; Larry A. Donoso, MD, PhD

Arch Ophthalmol. 1992;110(3):399-404.


Abstract

• Monoclonal antibody (MAb) 8-1H defines a highly conserved ocular melanoma-associated antigen. Based on a potential binding site of MAb8-1, we identified, molecularly cloned, and sequenced the gene, encoding this melanoma-associated antigen from a uveal melanoma copy DNA library. Nucleotide sequence analysis of the melanoma-associated antigen revealed characteristics of a membrane-bound protein of 238 amino acids (approximately 25 kd) with four transmembrane domains. The sequence of the ocular melanoma-associated antigen is identical to the sequence of a recently reported cutaneous melanomaassociated antigen, substantiating our previous studies regarding common antigens between ocular and cutaneous melanoma. In addition, the melanomaassociated antigen shares sequence homology with a number of transmembrane proteins that appear to be involved in growth regulation. The implication of the biological function of this ocular melanoma-associated antigen, its relevance to the malignant phenotype, and clinical applications of the molecular characterization of this melanoma-associated antigen are described.



Author Affiliations

From the Retina Service, Wills Eye Hospital and Thomas Jefferson University (Drs Wang, Earley, and Donoso), and the Oncology Service, Wills Eye Hospital (Dr Shields), Philadelphia, Pa. Dr Wang is the Robert D. McCallum Research Scholar, and Dr Donoso is the Thomas D. Duane Clinical and Research Professor of Ophthalmology, Wills Eye Hospital.


Footnotes

Accepted for publication September 11, 1991.

Reprint requests to Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107-5598 (Dr Donoso).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.